Topical non‐steroidal anti‐inflammatory drugs are not the mainstay of prophylaxis and treatment for pseudophakic cystoid macular oedema: Response.

Topical non-steroidal anti-inflammatory drugs are not the mainstay of prophylaxis and treatment for pseudophakic cystoid macular oedema: Response We thank Levitz, Lim, Grzybowski and Kim, well-known and prolific correspondents on scientific publications, for their interest in, and kind comments upon, our recent publication[1] on pseudophakic cystoid macular oedema (PCMO); "The review article does allude to the challenges faced in providing advice on prophylaxis of PCMO" and "The authors have provided a significant review of a complex topic".[2] However, in relation to other comments, we feel the correspondents may have confused the semantics of what we believe is a balanced review, stating they would "Like to highlight several aspects of the quoted literature which may be misconstrued". Topical NSAIDs are not the mainstay of prophylaxis and treatment for pseudophakic cystoid macular oedema. [Extracted from the article]